Skip to content

Pulse Biosciences, Inc.

PLSE

CIK 0001625101

← back to feed
Revenue (TTM)
$487K
Q1 May 2026
Net Income (TTM)
−$73.93M
−35.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.99
Q1 May 2026
Gross Margin
-33.3%
Q1 May 2026
Operating Margin
-15,982.8%
Q1 May 2026
Net Margin
-15,180.5%
Q1 May 2026
Free Cash Flow (TTM)
−$44.59M
Q1 May 2026
Cash
$68.32M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
69.21M sh
Q1 May 2026

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings